MEDITE Cancer Diagnostics Inc (MDIT) - Product Pipeline Analysis, 2017 Update

  • ID: 4377311
  • Company Profile
  • 37 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Cytyc Surgical Products
  • Dako A/S
  • Sakura Finetek USA, Inc.
  • TriPath Imaging Inc
  • MORE
Summary

MEDITE Cancer Diagnostics Inc (MEDITE), formerly CytoCore, Inc., specializes in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection, risk assessment and diagnosis of cancer and related diseases. Its major devices include ultrasonic decalcification instruments, tissue processing instruments, freezing microtome, cryostats, linear staining systems, staining systems, and cytology screening systems. The company products find application in processing tissue, cell collection ranging from processing to diagnosis. These devices and consumables are manufactured at is facility in Burgdorf, Germany. The company sells its products through a direct sale force located in Germany, Poland and the US, and also through independent distributors. The company is headquartered in Orlando, Florida, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company MEDITE Cancer Diagnostics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
*Note: Some sections may be missing if data is unavailable for the company.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Cytyc Surgical Products
  • Dako A/S
  • Sakura Finetek USA, Inc.
  • TriPath Imaging Inc
  • MORE
MEDITE Cancer Diagnostics Inc Company Overview
MEDITE Cancer Diagnostics Inc Company Snapshot
MEDITE Cancer Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
MEDITE Cancer Diagnostics Inc - Pipeline Analysis Overview
Business Description
MEDITE Cancer Diagnostics Inc - Key Facts
MEDITE Cancer Diagnostics Inc - Major Products and Services
MEDITE Cancer Diagnostics Inc Pipeline Products by Development Stage
MEDITE Cancer Diagnostics Inc Pipeline Products Overview
AIPS Imager
AIPS Imager Product Overview
AIPS Workstation
AIPS Workstation Product Overview
BreastPap
BreastPap Product Overview
Diagnostic Assay - HPV
Diagnostic Assay - HPV Product Overview
Genetic Biomarker Assay - Cervical Cancer
Genetic Biomarker Assay - Cervical Cancer Product Overview
Genetic Biomarker Assay - Uterine Cancer
Genetic Biomarker Assay - Uterine Cancer Product Overview
Screening Assay - Anal Cancer
Screening Assay - Anal Cancer Product Overview
Screening Assay - Bladder Cancer
Screening Assay - Bladder Cancer Product Overview
Screening Assay - Breast Cancer
Screening Assay - Breast Cancer Product Overview
Screening Assay - Endometrial Cancer
Screening Assay - Endometrial Cancer Product Overview
Screening Assay - Lung Cancer
Screening Assay - Lung Cancer Product Overview
Screening Assay - Oral Cancer
Screening Assay - Oral Cancer Product Overview
SoftKit
SoftKit Product Overview
MEDITE Cancer Diagnostics Inc - Key Competitors
MEDITE Cancer Diagnostics Inc - Key Employees
MEDITE Cancer Diagnostics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
MEDITE Cancer Diagnostics Inc, Recent Developments
May 10, 2017: MEDITE Cancer Diagnostics Announces Reorganization of Germany Operations
Apr 28, 2017: MEDITE Cancer Diagnostics Announces Reorganization of Germany Operations
Apr 27, 2017: MEDITE Cancer Diagnostics Appoints Susan Weisman as Chief Financial Officer
Mar 07, 2017: MEDITE Cancer Diagnostics Appoints Eric M. Goehausen to Board of Directors
Nov 17, 2015: MEDITE Cancer Diagnostics Reports a Profitable Third Quarter and Nine Month 2015 Results
May 11, 2015: MEDITE Cancer Diagnostics Reports 2014 Year End Results along with Expectations for 2015
Mar 20, 2015: MEDITE Cancer Diagnostics Announces Granted Patent Lab-in-One Automation System
Dec 11, 2014: MEDITE Cancer Diagnostics Becomes New Name for CytoCore
Nov 21, 2014: CytoCore Reports Record YTD And 3rd Quarter Sales
Jun 18, 2014: MEDITE Files U.S. GAAP Financial Statements
Appendix
Methodology
About
Contact
Disclaimer

List of Tables
MEDITE Cancer Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
MEDITE Cancer Diagnostics Inc Pipeline Products by Equipment Type
MEDITE Cancer Diagnostics Inc Pipeline Products by Indication
MEDITE Cancer Diagnostics Inc, Key Facts
MEDITE Cancer Diagnostics Inc, Major Products and Services
MEDITE Cancer Diagnostics Inc Number of Pipeline Products by Development Stage
MEDITE Cancer Diagnostics Inc Pipeline Products Summary by Development Stage
AIPS Imager - Product Status
AIPS Imager - Product Description
AIPS Workstation - Product Status
AIPS Workstation - Product Description
BreastPap - Product Status
BreastPap - Product Description
Diagnostic Assay - HPV - Product Status
Diagnostic Assay - HPV - Product Description
Genetic Biomarker Assay - Cervical Cancer - Product Status
Genetic Biomarker Assay - Cervical Cancer - Product Description
Genetic Biomarker Assay - Uterine Cancer - Product Status
Genetic Biomarker Assay - Uterine Cancer - Product Description
Screening Assay - Anal Cancer - Product Status
Screening Assay - Anal Cancer - Product Description
Screening Assay - Bladder Cancer - Product Status
Screening Assay - Bladder Cancer - Product Description
Screening Assay - Breast Cancer - Product Status
Screening Assay - Breast Cancer - Product Description
Screening Assay - Endometrial Cancer - Product Status
Screening Assay - Endometrial Cancer - Product Description
Screening Assay - Lung Cancer - Product Status
Screening Assay - Lung Cancer - Product Description
Screening Assay - Oral Cancer - Product Status
Screening Assay - Oral Cancer - Product Description
SoftKit - Product Status
SoftKit - Product Description
MEDITE Cancer Diagnostics Inc, Key Employees
MEDITE Cancer Diagnostics Inc, Subsidiaries
Glossary

List of Figures
MEDITE Cancer Diagnostics Inc Pipeline Products by Equipment Type
MEDITE Cancer Diagnostics Inc Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • TriPath Imaging Inc
  • Thermo Fisher Scientific Inc
  • Sakura Finetek USA, Inc.
  • Leica Biosystems Nussloch Gmbh
  • Dako A/S
  • Cytyc Surgical Products
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll